Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 15/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.56 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24997553 | 0.84 | PTAFR (0.60) | PTAFROPRK1PDE4DGABRA1GABRA5 | |
| SCHEMBL5664181 | 0.81 | PTAFR (0.57) | PTAFROPRK1PDE4DGABRA1GABRA5 | |
| SCHEMBL8928539 | 0.80 | PTAFR (0.66) | PTAFROPRK1PDE4DGABRA1GABRA5 | |
| SCHEMBL29603453 | 0.79 | PTAFR (0.76) | PTAFROPRK1PDE4D | |
| SCHEMBL24442315 | 0.79 | PTAFR (0.76) | PTAFROPRK1PDE4D | |
| SCHEMBL24442040 | 0.79 | PTAFR (0.76) | PTAFROPRK1PDE4D | |
| SCHEMBL10435178 | 0.79 | PTAFR (0.76) | PTAFROPRK1PDE4D | |
| SCHEMBL29602921 | 0.79 | PTAFR (0.76) | PTAFROPRK1PDE4D | |
| SCHEMBL29603369 | 0.79 | PTAFR (0.76) | PTAFROPRK1PDE4D | |
| SCHEMBL24442198 | 0.78 | PTAFR (0.74) | PTAFROPRK1PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7015213-B1 | Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2006-03-21 | — | — | US | disclosed |